Main news


FDA Clears Architect Stat High-Sensitivity Troponin Test for MI
FDA Clears Architect Stat High-Sensitivity Troponin Test for MI The US Food and Drug Administration (FDA) has approved the Architect Stat (Abbott Laboratories) high-sensitivity troponin-I assay, which can detect myocardial infarction (MI) faster and more accurately than other troponin tests, according to the company.


Editorial Activity

cardiology book

World Heart Day 2019
World Heart Day 2019 This year on World Heart Day, as part of our mission to ensure heart health equity for all, we want to create a global community of Heart Heroes … people from all walks of life who are acting now to live longer, better, heart-healthy lives by making a promise: for MY HEART, for YOUR HEART, for ALL OUR HEARTS.


ESC 2019: Wrap up in Russian - Live and interactive programme
ESC 2019: Wrap up in Russian - Live and interactive programme In collaboration with the Russian Society of Cardiology, this programme is designed to present a selection of scientific highlights from ESC Congress and discuss clinical practice implications with experts.


ESC Congress 2019                      together with World Congress of Cardiology
ESC Congress 2019 together with World Congress of Cardiology ESC Congress 2019 together with World Congress of Cardiology Saturday 31 August - Wednesday 4 September 2019 Paris - France


Announcement of the European Congress of Cardiology
Announcement of the European Congress of Cardiology From August 31 to September 4, 2019, he Congress of the European Society of Cardiology in conjunction with the World Congress of Cardiology - will be held in Paris (France).


Trial Evaluating Sacubitril/Valsartan for HFpEF Misses Primary End Point
Trial Evaluating Sacubitril/Valsartan for HFpEF Misses Primary End Point Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September. Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).


ESC Congress 2019                      together with World Congress of Cardiology
ESC Congress 2019 together with World Congress of Cardiology Full detailed data from PARAGON-HF will be presented at the ESC Congress 2019 in September. Novartis announced topline results from the phase 3 PARAGON-HF study evaluating the safety and efficacy of sacubitril/valsartan (Entresto) in heart failure patients with preserved ejection fraction (HFpEF).


Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset
Certain Social, Behavioral Factors Associated With Diabetes and Hypertension Onset Education and exercise may determine early start of diabetes and hypertension. Select behavioral and social risk factors were correlated with early onset of hypertension and diabetes, a prospective cohort study found. At 3.5 years of follow-up, among the patients without diabetes at baseline, 4% developed diabetes, while 6.4% of the cohort without baseline hypertension developed hypertension, reported Matthew Pantell, MD, MS, of the University of California, San Francisco, and colleagues.


THE FEATS OF DOCTORS DURING  THE GREAT PATRIOTIC WAR (WORLD WAR II)
THE FEATS OF DOCTORS DURING THE GREAT PATRIOTIC WAR (WORLD WAR II) During the war years, more than 700 thousand doctors and medical professionals worked at the front. At the end of the war, 12.5% of all these people were killed, and this figure seriously exceeds the losses in each individual military unit. But despite the danger, they never gave up, and in the most extreme situations only the iron will helped them to pull hundreds of people from the other world, and again to return to the battlefields. They achieved amazing results, and during the entire war, thanks to medical workers, about 72 percent of wounded soldiers and 90 percent of sick people, that is, approximately 17 million people, returned to the system.